Electrocore Inc (ECOR)

$4.48 +0.17 (3.94%)
Market Cap 34.50M
Revenue (ttm) 25.18M
Net Income (ttm) -11.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -47.22%
Debt to Equity Ratio 0.00
Volume 134,700
Avg Vol 101,708
Day's Range N/A - N/A
Shares Out 7.47M
Stochastic %K 5%
Beta 0.27
Analysts Strong Sell
Price Target $21.35

Company Profile

electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also deve...

Industry: Medical Devices
Sector: Healthcare
Phone: 973 290 0097
Fax: 973 290 9171
Address:
200 Forge Way, Suite 205, Rockaway, United States
taxplanr
taxplanr Aug. 12 at 2:58 PM
$ECOR focus on Truvaga https://investor.electrocore.com/news-releases/news-release-details/electrocore-names-kelly-benning-accomplished-healthcare
0 · Reply
Mudloaf
Mudloaf Aug. 12 at 1:46 PM
$ECOR I see why everyone hates the ceo, buying 1000 shares is sad. Should have been 10,000 shares minimum.
1 · Reply
taxplanr
taxplanr Aug. 12 at 1:38 PM
$ECOR
0 · Reply
Mudloaf
Mudloaf Aug. 12 at 12:48 PM
$ECOR what conviction!
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Aug. 12 at 12:10 PM
$ECOR CEO purchased 1,000 shares at $4.23 for a total of $4,230. Goldberger Daniel S now owns 291,565 shares. https://ceo-buys.com
0 · Reply
Wickedkiwi
Wickedkiwi Aug. 11 at 6:59 PM
$ECOR one of my favorite things about this stock in the past was their ability to easily raise money when needed. Equity offerings with eager buyers aren’t that big of a deal. Now that the debt financing has begun, it paints a pretty dire picture for the company. Everyone within/connected to the company is not willing to pitch in more. I wouldn’t imagine it goes much below a $15 million valuation (close to cash value) without a bankruptcy announcement, but who knows.
0 · Reply
goodideastock
goodideastock Aug. 11 at 6:13 PM
$ECOR totally shit
1 · Reply
goodideastock
goodideastock Aug. 11 at 2:11 PM
$ECOR An extremely panicked sell-off, as if fleeing for one's life.
0 · Reply
Mnpois
Mnpois Aug. 10 at 1:50 PM
$ECOR no offering but 12% loan
1 · Reply
Mudloaf
Mudloaf Aug. 9 at 1:48 PM
$ECOR 1. these guys have a five year revenue CAGR of over 50%. That’s a good track record. If they think this loan will get them back to 50% growth I’m going to believe them. 2. The loan is a good deal for all parties. 12% interest isn’t bad and the principal isn’t due for 4 years. Much better than an equity offering now. 3. The numbers tell the story of a solid growing business here. There was some unwarranted hype six months ago that is now gone and the price is now good. I’ve reviewed all the earnings calls and reports and all I see is a small biotech company balancing growth with expenses, it’s not always smooth and perfect. Their five year record is sold and the value is here now
1 · Reply
Latest News on ECOR
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga

Aug 12, 2025, 8:00 AM EDT - 13 hours ago

electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga

electroCore, Inc. (ECOR) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 11:18 PM EDT - 5 days ago

electroCore, Inc. (ECOR) Q2 2025 Earnings Call Transcript

electroCore Announces Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 6 days ago

electroCore Announces Second Quarter 2025 Financial Results

electroCore Appoints James C. Theofilos to the Board of Directors

Aug 5, 2025, 8:00 AM EDT - 7 days ago

electroCore Appoints James C. Theofilos to the Board of Directors

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025

Jul 23, 2025, 8:00 AM EDT - 20 days ago

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025

electroCore to Participate in Upcoming Investor Conferences

Jul 22, 2025, 4:05 PM EDT - 21 days ago

electroCore to Participate in Upcoming Investor Conferences

electroCore, Inc. (ECOR) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:16 PM EDT - 3 months ago

electroCore, Inc. (ECOR) Q1 2025 Earnings Call Transcript

electroCore Announces First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 3 months ago

electroCore Announces First Quarter 2025 Financial Results

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

May 2, 2025, 8:00 AM EDT - 3 months ago

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

electroCore's Truvaga™ Now Works with the Apple Health app

May 1, 2025, 8:00 AM EDT - 3 months ago

electroCore's Truvaga™ Now Works with the Apple Health app

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

Apr 30, 2025, 8:00 AM EDT - 3 months ago

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

Apr 17, 2025, 8:00 AM EDT - 4 months ago

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

electroCore to Participate at the Planet MicroCap Showcase

Apr 16, 2025, 8:00 AM EDT - 4 months ago

electroCore to Participate at the Planet MicroCap Showcase

electroCore Named One of The Americas' Fastest Growing Companies by the Financial Times

Apr 3, 2025, 8:00 AM EDT - 4 months ago

electroCore Named One of The Americas' Fastest Growing Companies by the Financial Times

electroCore to Participate at the Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 4 months ago

electroCore to Participate at the Needham Virtual Healthcare Conference

electroCore Extends VA Contract for Five Years

Mar 31, 2025, 8:00 AM EDT - 4 months ago

electroCore Extends VA Contract for Five Years

electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 9:36 PM EDT - 5 months ago

electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript

electroCore Announces Full Year 2024 Financial Results

Mar 12, 2025, 4:05 PM EDT - 5 months ago

electroCore Announces Full Year 2024 Financial Results

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025

Mar 6, 2025, 8:00 AM EST - 5 months ago

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025

electroCore to Participate at Upcoming Investor Conferences

Mar 5, 2025, 8:00 AM EST - 5 months ago

electroCore to Participate at Upcoming Investor Conferences

electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal

Feb 27, 2025, 8:00 AM EST - 5 months ago

electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal

electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Feb 4, 2025, 8:00 AM EST - 6 months ago

electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

electroCore: An Opportunity In Medical And Wellness Device Innovation

Jan 14, 2025, 10:17 AM EST - 7 months ago

electroCore: An Opportunity In Medical And Wellness Device Innovation

electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM

Dec 30, 2024, 1:59 PM EST - 8 months ago

electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

Dec 17, 2024, 4:05 PM EST - 8 months ago

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

Nov 14, 2024, 8:00 AM EST - 9 months ago

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 9:18 PM EST - 9 months ago

electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript

electroCore Announces Third Quarter 2024 Financial Results

Nov 13, 2024, 4:01 PM EST - 9 months ago

electroCore Announces Third Quarter 2024 Financial Results

ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award

Nov 12, 2024, 4:01 PM EST - 9 months ago

ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Nov 8, 2024, 4:01 PM EST - 9 months ago

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

electroCore to Participate at LD Micro Main Event VXII

Oct 14, 2024, 8:00 AM EDT - 10 months ago

electroCore to Participate at LD Micro Main Event VXII

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

Sep 10, 2024, 8:00 AM EDT - 1 year ago

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:00 AM EDT - 1 year ago

electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

electroCore, Inc. (ECOR) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 4:27 AM EDT - 1 year ago

electroCore, Inc. (ECOR) Q2 2024 Earnings Call Transcript

electroCore Announces Second Quarter 2024 Financial Results

Aug 7, 2024, 4:01 PM EDT - 1 year ago

electroCore Announces Second Quarter 2024 Financial Results

electroCore Announces the Commercial Launch of TAC-STIM™

Jun 25, 2024, 8:00 AM EDT - 1 year ago

electroCore Announces the Commercial Launch of TAC-STIM™

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

Jun 3, 2024, 8:30 AM EDT - 1 year ago

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

electroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript

May 8, 2024, 10:19 PM EDT - 1 year ago

electroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript

electroCore Announces First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 1 year ago

electroCore Announces First Quarter 2024 Financial Results

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

May 1, 2024, 8:04 AM EDT - 1 year ago

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

electroCore Announces the Launch of Truvaga Plus® for General Wellness

Apr 8, 2024, 8:30 AM EDT - 1 year ago

electroCore Announces the Launch of Truvaga Plus® for General Wellness

electroCore Expands Intellectual Property Portfolio

Apr 2, 2024, 8:00 AM EDT - 1 year ago

electroCore Expands Intellectual Property Portfolio

electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 8:15 PM EDT - 1 year ago

electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

Mar 13, 2024, 4:05 PM EDT - 1 year ago

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

Mar 5, 2024, 4:05 PM EST - 1 year ago

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology

Dec 12, 2023, 8:00 AM EST - 1 year ago

electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology

Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023

Nov 15, 2023, 8:15 AM EST - 1 year ago

Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023

electroCore, Inc. (ECOR) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 10:27 PM EST - 1 year ago

electroCore, Inc. (ECOR) Q3 2023 Earnings Call Transcript

electroCore Announces Third Quarter 2023 Financial Results

Nov 8, 2023, 4:01 PM EST - 1 year ago

electroCore Announces Third Quarter 2023 Financial Results

taxplanr
taxplanr Aug. 12 at 2:58 PM
$ECOR focus on Truvaga https://investor.electrocore.com/news-releases/news-release-details/electrocore-names-kelly-benning-accomplished-healthcare
0 · Reply
Mudloaf
Mudloaf Aug. 12 at 1:46 PM
$ECOR I see why everyone hates the ceo, buying 1000 shares is sad. Should have been 10,000 shares minimum.
1 · Reply
taxplanr
taxplanr Aug. 12 at 1:38 PM
$ECOR
0 · Reply
Mudloaf
Mudloaf Aug. 12 at 12:48 PM
$ECOR what conviction!
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Aug. 12 at 12:10 PM
$ECOR CEO purchased 1,000 shares at $4.23 for a total of $4,230. Goldberger Daniel S now owns 291,565 shares. https://ceo-buys.com
0 · Reply
Wickedkiwi
Wickedkiwi Aug. 11 at 6:59 PM
$ECOR one of my favorite things about this stock in the past was their ability to easily raise money when needed. Equity offerings with eager buyers aren’t that big of a deal. Now that the debt financing has begun, it paints a pretty dire picture for the company. Everyone within/connected to the company is not willing to pitch in more. I wouldn’t imagine it goes much below a $15 million valuation (close to cash value) without a bankruptcy announcement, but who knows.
0 · Reply
goodideastock
goodideastock Aug. 11 at 6:13 PM
$ECOR totally shit
1 · Reply
goodideastock
goodideastock Aug. 11 at 2:11 PM
$ECOR An extremely panicked sell-off, as if fleeing for one's life.
0 · Reply
Mnpois
Mnpois Aug. 10 at 1:50 PM
$ECOR no offering but 12% loan
1 · Reply
Mudloaf
Mudloaf Aug. 9 at 1:48 PM
$ECOR 1. these guys have a five year revenue CAGR of over 50%. That’s a good track record. If they think this loan will get them back to 50% growth I’m going to believe them. 2. The loan is a good deal for all parties. 12% interest isn’t bad and the principal isn’t due for 4 years. Much better than an equity offering now. 3. The numbers tell the story of a solid growing business here. There was some unwarranted hype six months ago that is now gone and the price is now good. I’ve reviewed all the earnings calls and reports and all I see is a small biotech company balancing growth with expenses, it’s not always smooth and perfect. Their five year record is sold and the value is here now
1 · Reply
Mnpois
Mnpois Aug. 9 at 3:07 AM
$ECOR back when this was 7 I said this was shitt
0 · Reply
taxplanr
taxplanr Aug. 7 at 9:16 PM
$ECOR whiner wants to go with the model with slower growth And wants you to believe he is long 🤣
1 · Reply
taxplanr
taxplanr Aug. 7 at 8:02 PM
$ECOR nothing like a bear attack
1 · Reply
Wickedkiwi
Wickedkiwi Aug. 7 at 7:36 PM
$ECOR how do you go about putting a valuation on a company that has no interest in ever making money? There is no obvious bottom here. And all of this was completely unnecessary. Scaling the VA business would lead to profitability quite quickly if they scrapped Truvaga, which is doomed to fail anyway (already taken off of Amazon due to bad reviews because people don’t understand how to use the product and how to judge efficacy and they never will). It seems they have no interest in leveraging their actual competitive advantage, which is FDA approvals for gammacore. Mind blowing. I underestimated just how inept management really was. I’m sorry for everyone who owns shares here. We didn’t deserve this.
1 · Reply
Mudloaf
Mudloaf Aug. 7 at 2:52 PM
$ECOR happy to own this here. 20% growth and 85% margin trading at 1.3x sales. That’s nuts
0 · Reply
goodideastock
goodideastock Aug. 7 at 2:19 PM
$ECOR Such aggressive selling doesn't seem reasonable; it's suspected that a margin call triggered forced liquidation for someone.
1 · Reply
Wickedkiwi
Wickedkiwi Aug. 7 at 1:45 PM
$ECOR ded
0 · Reply
taxplanr
taxplanr Aug. 7 at 1:30 PM
$ECOR reading comprehension might be lacking "if we raise additional capital through debt financing"
0 · Reply
d_risk
d_risk Aug. 7 at 1:27 AM
$ECOR - electroCore, Inc. - 10Q - Updated Risk Factors ECOR’s new 2025 risk highlights include a restrictive Loan and Security Agreement with Avenue Venture Opportunities Fund II, imposing covenants and liens on assets that could limit financial flexibility, increase default risk, and prioritize debt repayment over common stockholders. #FinancialServices #CreditRisk #LoanAgreement #RiskManagement #DebtCovenants 🟢 Added 🟠 Removed https://d-risk.ai/ECOR/10-Q/2025-08-06
0 · Reply
Citten
Citten Aug. 6 at 11:08 PM
$ECOR Holy shit show. I’ve been focused on other earnings and just saw this. I’m guessing by price action it’s an ATM focused on survival rather than growth. I’ll come back later tonight to catch up. Can’t wait.
0 · Reply
Mudloaf
Mudloaf Aug. 6 at 10:17 PM
$ECOR just thinking it through, it looks like the founder came in and advised them to invest in growth rather than to focus on profitability. I agree. This is a $50 million company and needs to grow
1 · Reply
goodideastock
goodideastock Aug. 6 at 9:26 PM
$ECOR Sales are recovering and growing, and the outlook remains promising
0 · Reply